A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity

A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity

Service model changes at the North Staffordshire Rehabilitation Centre (UK) included switching spasticity treatment from onabotulinumtoxinA (onaBoNT-A) to abobotulinumtoxinA (aboBoNT-A). This noninterventional, retrospective, longitudinal study (NCT04396704) describes the clinical and economic outco...

Bibliografski detalji
Glavni autori:	Clive Bezzina, Vadim Degtiar, Natalya Danchenko, Pascal Maisonobe, Benjamin Davis, Emanuel Engmann, Elodie Guyon, Sophie Lecanuet, John Whalen
Format:	Članak
Jezik:	English
Izdano:	MDPI AG 2023-08-01
Serija:	Toxins
Teme:	adult limb spasticity stroke botulinumtoxinA abobotulinumtoxinA aboBoNT-A clinical practice
Online pristup:	https://www.mdpi.com/2072-6651/15/9/532

Slični predmeti

Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade After Approval: General Versus Local Anesthesia for BotulinumtoxinA Detrusor Injection
od: Heinrich Schulte-Baukloh, i dr.
Izdano: (2024-10-01)

Assessing the Use of BotulinumtoxinA for Hyperactive Urinary Tract Dysfunction a Decade after Approval: A Single-Blind Study to Evaluate the Reduction in Pain in OnabotulinumtoxinA Detrusor Injection Using Different Injection Needles
od: Heinrich Schulte-Baukloh, i dr.
Izdano: (2024-09-01)

Onset, longevity, and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines: a single-arm, prospective clinical study
od: Prager W, i dr.
Izdano: (2013-04-01)

Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot)
od: Keng He Kong, i dr.
Izdano: (2017-06-01)

Considerations on patient-related outcomes with the use of botulinum toxins: is switching products safe?
od: Fraint A, i dr.
Izdano: (2016-02-01)

Effectiveness of AbobotulinumtoxinA in Post-stroke Upper Limb Spasticity in Relation to Timing of Treatment
od: Jörg Wissel, i dr.
Izdano: (2020-02-01)

AbobotulinumtoxinA (Dysport<sup>®</sup>), OnabotulinumtoxinA (Botox<sup>®</sup>), and IncobotulinumtoxinA (Xeomin<sup>®</sup>) Neurotoxin Content and Potential Implications for Duration of Response in Patients
od: Malgorzata Field, i dr.
Izdano: (2018-12-01)

Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice
od: Richard D. Zorowitz, i dr.
Izdano: (2025-02-01)

Modelling Long-Term Outcomes and Risk of Death for Patients with Post-Stroke Spasticity Receiving Abobotulinumtoxina Treatment and Rehabilitation Therapy
od: Klemens Fheodoroff, i dr.
Izdano: (2022-08-01)

Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop
od: Harald Hefter, i dr.
Izdano: (2021-07-01)

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions
od: Mark F. Lew, i dr.
Izdano: (2021-01-01)

Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study
od: Alberto Esquenazi, i dr.
Izdano: (2023-10-01)

Long-term follow-up of intravesical abobotulinumtoxinA (Dysport®) injections in women with idiopathic detrusor overactivity
od: Mohammad Sajjad Rahnama'i, i dr.
Izdano: (2024-01-01)

Switching from onabotulinumtoxin-A to abobotulinumtoxin-A in children with cerebral palsy treated for spasticity: A retrospective safety and efficacy evaluation
od: Nigar Dursun, i dr.
Izdano: (2019-04-01)

Spotlight on botulinum toxin and its potential in the treatment of stroke-related spasticity
od: Kaku M, i dr.
Izdano: (2016-03-01)

The safety of botulinum neurotoxin type A's intraarticular application in experimental animals
od: Ana Dugonjić Okroša, i dr.
Izdano: (2023-06-01)

Early AbobotulinumtoxinA (Dysport®) in Post-Stroke Adult Upper Limb Spasticity: ONTIME Pilot Study
od: Raymond L Rosales, i dr.
Izdano: (2018-06-01)

Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults
od: Marcelo Riberto, i dr.
Izdano: (2022-11-01)

Goal Attainment after Treatment with Abobotulinumtoxina and a Tailored Home Therapy Programme in Children with Upper Limb Spasticity: Descriptive, Exploratory Analysis of a Large Randomized, Controlled Study
od: Jorge Carranza-del Río, i dr.
Izdano: (2022-12-01)

Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature Review
od: Alfonso Fasano, i dr.
Izdano: (2020-07-01)

Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
od: Travis J.W. Hassell, i dr.
Izdano: (2020-04-01)

Cost-effectiveness analysis of abobotulinumtoxinA for the treatment of cervical dystonia in the United Kingdom
od: Muthukumar M, i dr.
Izdano: (2017-04-01)

Factors Influencing the Surgical Decision in Dystonia Patients Referred for Deep Brain Stimulation
od: Carolina Gorodetsky, i dr.
Izdano: (2021-07-01)

Intradermal Micro-Dosing of AbobotulinumtoxinA for Face-Lifting: How Long Does It Last?
od: Rungsima Wanitphakdeedecha, i dr.
Izdano: (2020-06-01)

Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review
od: Hassan Galadari, i dr.
Izdano: (2021-02-01)

A Cost-Effectiveness and Budget Impact Analysis of AbobotulinumtoxinA in Greece
od: Nikolaos Nomikos, i dr.
Izdano: (2023-09-01)

Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data
od: François Giuliano, i dr.
Izdano: (2023-06-01)

Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?
od: Joely Kaufman-Janette, i dr.
Izdano: (2021-07-01)

Continuation of Long-Term Care for Cervical Dystonia at an Academic Movement Disorders Clinic
od: David Charles, i dr.
Izdano: (2013-04-01)

Delphi Consensus on the Management of Spanish Patients with Post-Stroke Hemiplegic Shoulder Pain Treated with Botulinum Toxin A: Result Study
od: Carlos Cordero-García, i dr.
Izdano: (2025-01-01)

Botulinumtoxin Improves both Generic and Disease-Specific Quality of Life in Cervical Dystonia
od: Daniel Weiss, i dr.
Izdano: (2017-10-01)

Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?
od: Amélie Huynh Le Maux, i dr.
Izdano: (2015-12-01)

Adult Spasticity International Registry Study: methodology and baseline patient, healthcare provider, and caregiver characteristics
od: Gerard E. Francisco, i dr.
Izdano: (2017-06-01)

New 9-aminoacridine derivatives as inhibitors of Botulinum neurotoxins and P. falciparum malaria
od: Tot Mikloš, i dr.
Izdano: (2013-01-01)

Changes in Cortical Activity in Stroke Survivors Undergoing Botulinum Neurotoxin Therapy for Treatment of Focal Spasticity
od: Kaleb Vinehout, i dr.
Izdano: (2021-12-01)

Direct Inhibition of Microglia Activation by Pretreatment With Botulinum Neurotoxin A for the Prevention of Neuropathic Pain
od: Xiaona Feng, i dr.
Izdano: (2021-12-01)

Combined Effects of Isokinetic Training and Botulinum Toxin Type A on Spastic Equinus Foot in Patients with Chronic Stroke: A Pilot, Single-blind, Randomized Controlled Trial
od: Nicoletta Cinone, i dr.
Izdano: (2019-04-01)

Isolation and Characterization of the Novel Botulinum Neurotoxin A Subtype 6
od: Molly S. Moritz, i dr.
Izdano: (2018-10-01)

The Role of Botulinum Toxin Type-A in Spasticity: Research Trends from a Bibliometric Analysis
od: Salvatore Facciorusso, i dr.
Izdano: (2024-04-01)

Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins
od: Hyun-Mi Oh, i dr.
Izdano: (2015-12-01)